Perbedaan Sinergi Inti Plastindo Tbk. dan UBC Medical Indonesia Tbk.: Sinergi Inti Plastindo Tbk. diperdagangkan di Rp128 (kapitalisasi pasar 139,85 M, volume 24 jam 66,98 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 4,2× kapitalisasi pasar Sinergi Inti Plastindo Tbk., dan Sinergi Inti Plastindo Tbk. lebih aktif diperdagangkan (66,98 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ESIP | LABS | |
|---|---|---|
Kapitalisasi Pasar | 139,85 M | 584,6 M |
Volume | 66,98 jt | 817,3 rb |
Lot | 669,81 rb | 8,17 rb |
Perputaran | 8,73 M | 120,01 jt |
Harga Rata-rata | 130,29 | 146,84 |
Nilai Transaksi | 8,73 M | 120,01 jt |
Harga Ekuilibrium Indikatif | 128 | 146 |
Volume Ekuilibrium Indikatif | 7,61 rb | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Selengkapnya di halaman ESIP →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →